Despite having a strong balance sheet and reduced cash burn, the risk of failure in commercialization and the absence of a clear path to profitability make this investment too risky.

The company's balance sheet consists of $381 million in cash and $18 million in debt. This results in a net cash position of $363 million which corresponds to $3.94 per share, assuming 92.1 shares ...

To calculate “Months Before Bankruptcy” I divided the TTM FCF burn by 12, which equals monthly cash burn. I then divide Cash and Equivalents on the balance sheet through 1Q22 by monthly cash burn.

A company's cash runway is calculated by dividing its cash hoard by its cash burn. When ImmunoPrecise Antibodies last reported its January 2025 balance sheet in March 2025, it had zero debt and ...

When Oramed Pharmaceuticals last reported its March 2025 balance sheet in May 2025, it had zero debt and cash worth US$131m. Importantly, its cash burn was US$10m over the trailing twelve months.

When Rallybio last reported its balance sheet in June 2021, it had zero debt and cash worth US$113m. Importantly, its cash burn was US$38m over the trailing twelve months. Therefore, from June ...

Agenus signals near-term strategic transactions and operational cash burn target below $50M amid BOT/BAL ... and 2 BOT/BAL licensing deals," each aimed at materially strengthening the balance sheet.

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success ...